In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...
Novo Nordisk announces positive results from phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity: Bagsværd, Denmark Monday, January 27, 2025, 13:00 ...
The pharmaceutical industry came up with medicine that stops people from craving processed, addictive foods and the food industry is in a panic.
In a phase 1b/2a trial subcutaneous amycretin demonstrated a safety profile similar to other incretin-based drugs . Adults ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have ...
"It's a disservice to Dr. Fauci that they felt this was necessary." -- Georges Benjamin, MD, executive director of the ...
Weight-loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. The NPA has previously urged patients to ...
Weight loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. In October, the MHRA told health ...
Shares of PMGC Holdings Inc. (Elab) surged more than 50% on Friday as the skin care and biopharma products company said its ...
Britain’s pharmacists have called for tougher regulation of weight-loss drugs after reports showed some online sellers have set targets for clinicians to process more than 20 patients every hour.
An observational analysis finds the drugs may lower the risk of substance abuse and cognitive issues. But the findings need clinical testing.